88 results on '"Siontis, Konstantinos"'
Search Results
2. Artificial intelligence electrocardiography for the evaluation of cardiac involvement in Fabry disease
3. Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy
4. Ventricular Tachycardia Ablation in Patients With Desmoplakin Cardiomyopathy
5. Arrhythmic prognosis according to left ventricular systolic dysfunction severity in cardiac sarcoidosis
6. Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy
7. Patient-Level Artificial Intelligence–Enhanced Electrocardiography in Hypertrophic Cardiomyopathy: Longitudinal Treatment and Clinical Biomarker Correlations
8. Data-Driven and Technology-Enabled Trial Innovations Toward Decentralization of Clinical Trials: Opportunities and Considerations
9. Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions
10. Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method
11. Invasive electrophysiological testing to predict and guide permanent pacemaker implantation after transcatheter aortic valve implantation: A meta-analysis
12. Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice
13. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial
14. Artificial Intelligence–Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts
15. Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up
16. The Role of Artificial Intelligence in Arrhythmia Monitoring
17. The precordial R′ wave: A novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia
18. Batch enrollment for an artificial intelligence-guided intervention to lower neurologic events in patients with undiagnosed atrial fibrillation: rationale and design of a digital clinical trial
19. Impact of Intramural Scar on Mapping and Ablation of Premature Ventricular Complexes
20. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation
21. Factors predictive for delayed enhancement in cardiac resonance imaging in patients undergoing catheter ablation of premature ventricular complexes
22. Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice
23. Electroanatomical Voltage Mapping to Distinguish Right-Sided Cardiac Sarcoidosis From Arrhythmogenic Right Ventricular Cardiomyopathy
24. Stepwise Approach for Ventricular Tachycardia Ablation in Patients With Predominantly Intramural Scar
25. Value of mapping and ablation of ventricular tachycardia targets within the coronary venous system in patients with nonischemic cardiomyopathy
26. Risk stratification in patients with frequent premature ventricular complexes in the absence of known heart disease
27. Role of Ambulatory Electrocardiographic Monitoring After Postoperative Atrial Fibrillation Related to Noncardiac Surgery
28. Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy
29. Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten
30. Significance of clinical ventricular tachycardias induced by antitachycardia pacing in patients with prior myocardial infarction
31. Endpoints for Successful Slow Pathway Catheter Ablation in Typical and Atypical Atrioventricular Nodal Re-Entrant Tachycardia: A Contemporary, Multicenter Study
32. Assessment of Positive Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy Using an Artificial Intelligence–Based Electrocardiographic Platform in Patients Treated With Mavacamten
33. Effect of Body Mass Index on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
34. B-20 | Interventional Cardiologists’ Perspectives and Knowledge Towards Artificial Intelligence
35. Postoperative atrial fibrillation: Prediction of subsequent recurrences with clinical risk modeling and artificial intelligence electrocardiography
36. Detection of cardiac sarcoidosis with the artificial intelligence–enhanced electrocardiogram
37. Intrapericardial position of an extravascular implantable cardioverter-defibrillator lead
38. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network)
39. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality
40. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy
41. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis
42. Prognostic value of positron emission tomography myocardial perfusion imaging beyond traditional cardiovascular risk factors: Systematic review and meta-analysis
43. Diagnostic tests often fail to lead to changes in patient outcomes
44. Perceived information gain from randomized trials correlates with publication in high–impact factor journals
45. Assessment of Disease Status and Treatment Response With Artificial Intelligence−Enhanced Electrocardiography in Obstructive Hypertrophic Cardiomyopathy
46. PO-05-127 LONG TERM OUTCOMES OF CATHETER ABLATION IN YOUNG ADULTS WITH ATRIAL FIBRILLATION
47. PO-04-071 OUTCOMES OF CATHETER ABLATION OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND PRIOR SURGICAL MYECTOMY
48. PO-01-024 ELECTROANATOMIC MAPPING AS AN EARLY DIAGNOSTIC TOOL IN ARRHYTHMOGENIC CARDIOMYOPATHY
49. PO-01-075 ROLE OF GENOTYPE IN RISK PREDICTION FOR ARRHYTHMOGENIC CARDIOMYOPATHIES
50. PO-01-179 EARLY AND LATE MYOCARDIAL EFFECTS OF PROTON BEAM CARDIAC RADIOABLATION: INSIGHTS FROM GENE EXPRESSION ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.